Navigation Links
Blueberry and green tea containing supplement protects against stroke damage
Date:3/3/2008

Tampa, Florida (March 4, 2008) A unique dietary supplement called NutraStem has been shown to have beneficial effects following experimental stroke. A nutritional supplement product, NutraStem also known as NT-020, is a proprietary formulation of blueberry, green tea, vitamin D3 and carnosine extracts- a combination of nutritional ingredients thought to be potent in protecting against brain damage.

Stroke is the third leading cause of death and the leading cause for disability in the U.S. with two of every 1,000 adults experiencing their firsts stroke in any given year, said Cesar V. Borlongan, PhD, of the Medical College of Georgia, lead author of a study that tested NT-020 post stroke effects in animal models. We explored how increasing the nutritive diet through NT-020 supplementation might render a therapeutically potent neurogenesis following stroke.

NutraStem was developed by Natura Therapeutics, Inc., based in Tampa, Florida and founded by neuroscientists from the University of South Florida.. NutraStem was designed to encourage the proliferation of adult stem cells, which have the potential to develop into most tissues and bone cells in the body and have the capacity to migrate toward problem or damaged areas.

A study, conducted jointly by scientists at the University of South Florida College of Medicine (Tampa) and the Medical College of Georgia (Augusta), examined two groups of laboratory animals in a double-blind procedure. One group received the dietary supplement for two weeks prior to undergoing surgical stroke. The second group did not receive the dietary supplement. Results, published online in the high-impact journal REJUVENATION RESEARCH ), showed that the group receiving NutraStem had greatly reduced neural damage in the brain and demonstrated significantly reduced motor deficits.

The numbers of new neurons found in the damaged brain of the treated rats was significantly higher, said co-author Paula Bickford, PhD, of the University of South Florida College of Medicine and co-founder of Natura Therapeutics, Inc. An important feature of our results is that the combination of agents used was 100 times more potent than previously published study results that examined each of the individual ingredients used by themselves.

Co-author Cyndy D. Sanberg, PhD, of Natura Therapeutics, Inc., noted that while eliminating detrimental calories has been found to be protective against stroke by reducing oxidative stress, the nutritive diet of NutraStem could enhance and augment that approach.

Our study found robust neuroprotective effects of the NT-020 formula, said Borlongan. Two weeks of NutraStem therapy lessened stroke-induced behavioral deficits, reduced stroke-induced infarcts and promoted the birth of new neurons. Our results provide a critical advance in the scientific and clinical arena by demonstrating the advantage of a multi-agent over a single agent regimen.


'/>"/>

Contact: Dr. Cesario V. Borlongan
cborlongan@mail.mcg.edu
706-733-0188
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related biology news :

1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
2. New study shows greenback cutthroat trout involved in recovery effort misidentified
3. American Chemical Society calls green chemistry bill a smart step
4. Salmon garnish points the way to green electronics
5. Using green chemistry to deliver cutting-edge drugs
6. Green skies: Engineers work may reduce jet travels role in global warming
7. A greenhouse in order to study the impact of climate change on plants
8. Green leather is in this season
9. Study involving more than 100 scientists provides new insights on green algae
10. Green alga genome project catalogs carbon capture machinery
11. Green algae -- the nexus of plant/animal ancestry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... , November 22, 2016 According to the ... IRIS, Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), ... published by MarketsandMarkets, the market is expected to grow from USD 10.74 ... CAGR of 16.79% between 2016 and 2022. ... ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... , Nov 15, 2016 Research and Markets ... Forecast to 2021" report to their offering. ... ... 16.18 Billion by 2021 from USD 6.21 Billion in 2016, growing ... Growth of the bioinformatics market is driven by the growing ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... 2016 The U.S. Biotechnology industry ... billion of revenue and some $890 billion of total ... global biopharmaceuticals, and this figure is expected to exceed ... up these four equities for assessment: Northwest Biotherapeutics Inc. ... ACAD ), Acorda Therapeutics Inc. (NASDAQ: ...
(Date:12/4/2016)... -- In five studies being presented today during the 58th ... in San Diego , researchers are ... of life-saving treatments to patients with a variety of ... therapies directly to the sites in the body where ... advantage over traditional, systemic methods. The studies highlight the ...
(Date:12/2/2016)... , Dec. 2, 2016 More than $4.3 million ... Helix Medals dinner ( DHMD ). The gala was held at ... New York City and honored Alan Alda ... respectively, to health and medicine and the public understanding of ... in 2006, the event has raised $40 million for the ...
(Date:12/2/2016)... -- CytRx Corporation (NASDAQ: CYTR ), a ... announced the appointment of Earl Warren Brien , ... healthcare investor, to its Board of Directors. ... strategic experience at the highest level," said Steven ... of the world,s leading orthopedic surgeons, Dr. Brien has ...
Breaking Biology Technology: